Towns Co., Ltd. has acquired ClearBo Technologies to enhance its diagnostic capabilities in chronic diseases and leverage AI-driven medical device solutions.
Information on the Target
Towns Co., Ltd. specializes in the manufacturing of rapid diagnostic kits for infectious diseases. In line with its medium-term management plan, the company aims to enhance its diagnostic technologies for chronic diseases and expedite the establishment of a medical data infrastructure. To achieve these objectives, Towns has decided to acquire ClearBo Technologies, a medical device and medical systems trading company based in Chuo Ward, Tokyo.
ClearBo Technologies is known for its expertise in leveraging artificial intelligence to discover medical devices and software as a medical device (SaMD). The company provides a comprehensive suite of services, including regulatory approval in Japan, sales, implementation, and customer support. For the fiscal year ending March 2025, ClearBo reported sales of 71 million yen, an operating loss of 305 million yen, and a net asset deficit of 398 million yen.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview in Japan
The medical device industry in Japan is one of the largest and most advanced in the world, characterized by a robust regulatory framework and a high demand for innovative healthcare solutions. Jap
Similar Deals
タウンズ
invested in
クレアボ・テクノロジーズ
in 2025
in a Buyout deal
Disclosed details
Transaction Size: $1M
Revenue: $0M
EBIT: $0M
Net Income: $0M